Commercialization of Nanotechnology Innovations from Oak Ridge National Laboratory

UT-Battelle, LLC, acting under its Prime Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy (DOE) for the management and operation of the Oak Ridge National Laboratory (ORNL), is seeking commercialization partners for its Methods for Immunoregulation by Modulating Plasminogen-Apple-Nematode (PAN) Domain-Containing Proteins. The ORNL Technology Transfer , 2026 for the following patent pending technologies: 4200 – A PROTEIN DOMAIN MODULATING HOST-CELL INVASION Infection by specific microbes can confer beneficial phenotypes in plants including nitrogen fixation by bacteria, for example. However, the same molecular mechanisms that lead to colonization by symbionts can facilitate infection by disease-causing microbes and parasites in plants and animals. This invention shows that the presence of a fully functional protein domain leads to suppression of host immunity to facilitate host-cell invasion by symbionts, pathogens and parasites across eukaryotic organisms. Specific modification of essential amino acids in this domain will lead to induction of defense responses to prevent host-cell invasion. Therefore, this domain and its essential amino acids can be engineered to facilitate or prevent host-cell invasion by organisms including bacteria, fungi and obligate parasites such as nematodes, Rickettsia and Plasmodium sp. Applications and Industries Healthcare Biology Leslie Smith Alternative

Point of Contact Sue Burchfield